Laboratorio Reig Jofre (XMAD:RJF) E10: €0.13 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAD:RJF Laboratorio Reig Jofre SA XMAD:RJF
80 GF Score
Price €2.62
GF Value €2.72
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Laboratorio Reig Jofre E10?

Laboratorio Reig Jofre XMAD:RJF 80 E10 is €0.13 as of Mar. 2026. GuruFocus rates XMAD:RJF with a GF Score™ of 80/100 and a GF Value™ of €2.72 (Fairly Valued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Laboratorio Reig Jofre's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.038. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.13 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Laboratorio Reig Jofre's average E10 Growth Rate was -7.10% per year. During the past 3 years, the average E10 Growth Rate was -14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Laboratorio Reig Jofre was -11.20% per year. The lowest was -20.60% per year. And the median was -14.80% per year.

As of today (2026-07-18), Laboratorio Reig Jofre's current stock price is €2.62. Laboratorio Reig Jofre's E10 for the quarter that ended in Mar. 2026 was €0.13. Laboratorio Reig Jofre's Shiller PE Ratio of today is 20.15.

During the past 13 years, the highest Shiller PE Ratio of Laboratorio Reig Jofre was 24.54. The lowest was 6.47. And the median was 17.54.


Laboratorio Reig Jofre  (XMAD:RJF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Laboratorio Reig Jofre's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=2.62/0.13
=20.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Laboratorio Reig Jofre was 24.54. The lowest was 6.47. And the median was 17.54.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Laboratorio Reig Jofre E10 Related Terms


Laboratorio Reig Jofre E10 Historical Data

* Premium members only.

The historical data trend for Laboratorio Reig Jofre's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorio Reig Jofre E10 Chart

Laboratorio Reig Jofre Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.21 0.14 0.13 0.13

Laboratorio Reig Jofre Quarterly Data
Mar21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.13 0.13 0.13 0.13

XMAD:RJF vs ZTS, UTHR, VTRS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorio Reig Jofre Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Laboratorio Reig Jofre's Shiller PE Ratio falls into.


XMAD:RJF
80GF Score
Laboratorio Reig Jofre SA XMAD:RJF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Laboratorio Reig Jofre E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Laboratorio Reig Jofre's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.038/129.8600*129.8600
=0.038

Current CPI (Mar. 2026) = 129.8600.

Laboratorio Reig Jofre Quarterly Data

per share eps CPI Adj_EPS
201603 0.031 98.638 0.041
201606 0.021 100.333 0.027
201609 0.027 99.737 0.035
201612 0.043 101.842 0.055
201703 0.033 100.896 0.042
201706 0.011 101.848 0.014
201709 0.008 101.524 0.010
201712 0.088 102.975 0.111
201803 0.035 102.122 0.045
201806 0.011 104.165 0.014
201809 0.019 103.818 0.024
201812 0.078 104.193 0.097
201903 0.038 103.488 0.048
201906 0.008 104.612 0.010
201909 -0.010 103.905 -0.012
201912 0.035 105.015 0.043
202003 0.043 103.469 0.054
202006 0.008 104.254 0.010
202009 0.020 103.521 0.025
202012 0.004 104.456 0.005
202103 0.048 104.857 0.059
202106 -0.001 107.102 -0.001
202109 0.020 107.669 0.024
202112 0.000 111.298 0.000
202206 0.000 118.044 0.000
202209 0.009 117.221 0.010
202212 0.049 117.650 0.054
202303 0.049 118.948 0.053
202306 0.024 120.278 0.026
202309 0.028 121.343 0.030
202312 0.050 121.300 0.054
202403 0.041 122.762 0.043
202406 0.028 124.409 0.029
202409 0.031 123.121 0.033
202412 0.060 124.753 0.062
202503 0.046 125.531 0.048
202506 -0.026 127.251 -0.027
202509 0.004 126.840 0.004
202512 0.040 128.400 0.040
202603 0.038 129.860 0.038

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.13 mean?
Laboratorio Reig Jofre (XMAD:RJF) has a E10 of €0.13 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Laboratorio Reig Jofre and its competitors.
Is Laboratorio Reig Jofre's E10 too high?
Laboratorio Reig Jofre's current E10 is €0.13. Overall, Laboratorio Reig Jofre has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Laboratorio Reig Jofre's E10 compare to ZTS and UTHR?
Laboratorio Reig Jofre's E10 of €0.13 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Laboratorio Reig Jofre and its competitors. Laboratorio Reig Jofre's current E10 is €0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorio Reig Jofre stock overvalued right now?
Based on GuruFocus' analysis, Laboratorio Reig Jofre (XMAD:RJF) is currently considered Fairly Valued. The stock's GF Value™ is €2.72, compared to a current price of €2.62 — trading 3.7% below its estimated fair value. The current E10 is €0.13. Laboratorio Reig Jofre's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Laboratorio Reig Jofre (XMAD:RJF), the current E10 is €0.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Laboratorio Reig Jofre (XMAD:RJF) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorio Reig Jofre stock appears to be undervalued. The current stock price of €2.62 is trading 3.7% below its estimated GF Value™ of €2.72. GuruFocus considers Laboratorio Reig Jofre to be Fairly Valued.

Key valuation signals for XMAD:RJF:

  • E10: €0.13
  • GF Value™: €2.72 vs. price of €2.62 (3.7% below fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the XMAD:RJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Laboratorio Reig Jofre Business Description

Other Exchanges 0RB1:UKFEQ1:Germany
Address Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.
80GF Score

Get the complete analysis for XMAD:RJF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.62
Price
€2.72
GF Value